The sector had an upbeat earnings season. But continued weakness in China and U.S. tariffs could leave even the most exclusive brands vying for share of pocket.
Related Posts
The ‘weight loss trade’ has stalled. What it will take to revive investor interest
The initial euphoria over the GLP-1 drugs like Ozempic has mellowed, but catalysts expected in 2025 could energize investor interest in the stocks.
Trump is stacking his White House roster with uber-rich backers
President-elect Donald Trump is filling his next administration with billionaires and other mega-wealthy figures.
UBS upgrades this location-sharing app, says strong ad revenue can lead to big gains ahead
The bank upgraded the location-sharing platform to buy from neutral.